Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants as biomarkers for progression and resistance in multiple myeloma.

Cancer genetics - 1 Apr 2021

Montel Rachel A, Gregory Matthew, Chu Tinchun, Cottrell Jessica, Bitasktsis Constantine, Chang Sulie L

Abstract excerpt

Technical advances in genome sequencing, in particular whole-genome sequencing (WGS), provide adequate tools to understanding cancer at the molecular level while specifically focusing on genetic variants that contribute to the causation and progression of pathogenic cancers. Multiple myeloma (MM), a malignant disease of plasma cells that is marked as rare yet incurable, may be diagnosed by WGS tools, as this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Disease Progression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Regulatory Networks

Share to Genes, p53

Share to Genes, ras

Share to Multiple Myeloma

Share to NADH Dehydrogenase

Share to Software

Source

Open in PubMed Open full text

Identifiers

PMID: 33338886
DOI: 10.1016/j.cancergen.2020.12.001
PMCID: PMC8688903

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants as biomarkers for progression and resistance in multiple myeloma.PMID 33338886Read ↗

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.Semantic proximity Read ↗

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.Semantic proximity Read ↗

Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technologySemantic proximity Read ↗

Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma.Semantic proximity Read ↗

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.Semantic proximity Read ↗

Characterization of driver mutations identifies gene signatures predictive of prognosis and treatment sensitivity in multiple myeloma.Semantic proximity Read ↗

[Current state of genetic analysis in multiple myeloma and future perspectives].Semantic proximity Read ↗

Novel genomic findings in multiple myeloma identified through routine diagnostic sequencingSemantic proximity Read ↗

Identification of mutation gene prognostic biomarker in multiple myeloma through gene panel exome sequencing and transcriptome analysis in Chinese population.Semantic proximity Read ↗

Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathwaysSemantic proximity Read ↗

Genome-wide association study identifies multiple susceptibility loci for multiple myeloma.Semantic proximity Read ↗

Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.